Amplified CDK2 and cdc2 activities in primary colorectal carcinoma

Cancer

Volumn 85, Issue 3, 1999, Pages 546-553

  Kim, Jong Hun ^a   Kang, Min Jeong ^a   Park, Chul Uhng ^a   Kwak, Hee Jin ^a   Hwang, Yong ^a   Koh, Gou Young ^a,b  

^a Chonbuk National University Medical School   (South Korea)

^b Chonbuk National University   (South Korea)

Author keywords

Cell cycle; Colorectal carcinoma; Cyclin; Dependent kinase

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE;

ADULT; AGED; ARTICLE; CANCER STAGING; CELL CYCLE; CELL CYCLE S PHASE; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; BLOTTING, WESTERN; CDC2 PROTEIN KINASE; CDC2-CDC28 KINASES; CELL DIVISION; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PROTEIN-SERINE-THREONINE KINASES;

EID: 0345369607     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990201)85:3<546::AID-CNCR5>3.0.CO;2-0     Document Type: Article

References (29)

1. Hunter T, Pines J. Cyclins and cancer. Cell 1991;66:1071-4.
2. Sherr CJ. Mammalian G1 cyclins. Cell 1993;73:1059-65.
3. Hunter T, Pines J. Cyclins and cancer II: cyclin D and CDK inhibitors come to age. Cell 1994;79:573-82.
4. Sherr CJ. G1 phase progression; cycling on cue. Cell 1994; 79:551-5.
5. Lees E. Cyclin dependent kinase regulation. Curr Opin Cell Biol 1995;7:773-80.
6. Morgan DO. Principles of CDK regulation. Nature 1995;374: 131-4.
7. Harper JW, Elledge SJ. CDK inhibitors in development and cancer. Curr Opin Genet Dev. 1996;6:56-64.
8. Sherr CJ. Cancer cell cycle. Science 1996;274:1672-7.
9. Leach FS, Elledge S, Sherr CJ, Willson JKV, Markowitz S, Kinzler KW, et al. Amplifications of cyclin genes in colorectal carcinomas. Cancer Res 1993;53:1986-9.
10. Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, et al. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 1994;54: 4813-7.
11. Schauer IE, Siriwardana S, Langan TA, Sclafani A. Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in nonsmall cell and small cell lung cancer. Proc Natl Acad Sci U S A 1994;91:7828-31.
12. Dutta A, Chandra R, Leiter LM, Lester S. Cyclins as markers of tumor proliferation: immunohistochemical studies in breast cancer. Proc Natl Acad Sci U S A 1995;92:5386-90.
13. Nakagawa H, Zukerberg LZ, Togawa K, Meltzer SJ, Nishihara T, Rustgi AK. Human cyclin D1 oncogene and esophageal squamous cell carcinoma. Cancer 1995;76:541-9.
14. Gay-Bablin J, Zalvide J, Fox MP, Knickerbocker CJ, Decarpirio JA, Keyomarsi K. Cyclin E, a redundant cyclin in breast cancer. Proc Natl Acad Sci U S A 1996;93:15215-20.
15. Polyak K, Hamilton SR, Vogelstein B, Kinzler KW. Early alterations of cell-cycle-regulated gene expression in colorectal neoplasia. Am J Pathol 1996;149:381-7.
16. Van Diest PJ, Michaelides RJ, Jannink L, Van der Valk P, Peterse HL, De jong JS, et al. Cyclin D1 expression in invasive breast cancer: correlation and prognostic value. Am J Pathol 1996;150:705-11.
17. Ikeda K, Monden T, Tsujie M, Izawa H, Yamamoto H, Ohnishi T, et al. Cyclin D, CDK4 and p16 expression in colorectal cancer. Jpn J Clin Med 1996;54:1054-9.
18. Tominaga O, Nita ME, Nagawa H, Fujii S, Tsuruo T, Muto T. Expression of cell cycle regulators in human colorectal cancer cell lines. Jpn J Cancer Res 1997;88:855-60.
19. Astler V, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 193;139:846-52.
20. Park SK, Kang SK, Lee DY, Kang MJ, Kim SH, GY Koh. Temporal expressions of cyclins and cyclin dependent kinases during renal development and compensatory growth. Kidney Int 1997;51:762-9.
21. Kang MJ, GY Koh. Differential and dramatic changes of cyclin dependent kinase activities in cardiomyocytes during the neonatal period. J Mol Cell Cardiol 1997;29:1767-77.
22. Bravo R, Frank R, Blunell PA, MacDonald-Bravo H. Cyclin /PCNA is the auxiliary protein of DNA polymerase-gamma. Nature 1987;326:515-7.
23. Connolly KM, Bogdanffy MS. Evaluation of proliferating cell nuclear antigen (PCNA) as an endogenous marker of cell proliferation in the rat liver: a dual-stain comparison with 5-bromo-2′-deoxyuridine. J Histochem Cytochem 1993;41:1-6.
24. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-31.
25. Kallakury BV, Sheehan CE, Ambros RA, Fisher HA, Kaufman RP Jr., Ross JS. The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma. Cancer 1997;80:753-63.
26. Jonsson ZO, Hubscher U. Proliferating cell nuclear antigen: more than a clamp for DNA polymerase. Bioessays 1997;19: 967-75.
27. Biade S, Sobol RW, Wilson SH. Impairment of proliferating cell nuclear antigen dependent apurinic/apyrimidinic site repair on linear DNA. J Biol Chem 1998;273:898-902.
28. Texeira C, Pratt MA. CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells. Mol Endocrinol 1997;11:1191-1202.
29. Iseki H, Ko TC, Xue XY, Seapan A, Hellmich MR, Townsend CM Jr. Cyclin-dependent kinase inhibitors block proliferation of human gastric cancer cells. Surgery 1997;122:187-94.